Skip to main content
. 2023 Feb 3;147(11):2083–2092. doi: 10.3945/jn.117.256107

TABLE 3.

Effect of maternal choline supplementation on the concentration of choline metabolites in the female placentas at E15.5 and E18.51

E15.5 E18.5
1× choline 2× choline 4× choline 1× choline 2× choline 4× choline
Choline, μmol/g tissue 1.30 ± 0.12a 1.07 ± 0.12a 1.12 ± 0.12a 1.33 ± 0.09a 1.13 ± 0.09a 1.18 ± 0.09a
Acetylcholine, pmol/g tissue 89 ± 18a 28 ± 17b 22 ± 13b 7 ± 3a 14 ± 4b 44 ± 7c
TMAO, nmol/g tissue 7 ± 7a 44 ± 7b 126 ± 7c 17 ± 10a 57 ± 10b 135 ± 10c
Phosphocholine, nmol/g tissue 525 ± 40a 554 ± 40a 600 ± 40a 248 ± 15a 306 ± 15b 312 ± 15b
Phosphatidylcholine, μmol/g tissue 23 ± 1a 24 ± 1a 25 ± 1a 19 ± 1a 22 ± 1b 23 ± 1b
Glycerophosphocholine, nmol/g tissue 84 ± 22a 133 ± 21a,b 162 ± 21b 153 ± 29a 123 ± 29a 199 ± 29a
Sphingomyelin, μmol/g tissue 8.03 ± 0.47a 7.90 ± 0.46a 8.07 ± 0.46a 6.94 ± 0.33a 6.71 ± 0.33a 7.61 ± 0.33a
Betaine, μmol/g tissue 6.38 ± 0.56a 6.22 ± 0.56a 6.66 ± 0.56a 6.55 ± 0.45a 7.05 ± 0.45a 5.71 ± 0.45a
1

Values are means ± SEMs, n = 7 dams/group for each gestational day. Means in a row for the same gestational day without a common superscript letter differ, P ≤ 0.05. E, gestational day; TMAO, trimethylamine N–oxide.